Acute Lower-Extremity Ischemia in a Patient with COVID-19

被引:7
作者
Ahmad, Hadia [1 ]
Shubair, Swhaeb M. [1 ]
Kruer, James [1 ]
Hatoum, Chehada Anthony [1 ]
机构
[1] Northeast Georgia Med Ctr, Dept Internal Med, Gainesville, GA 30501 USA
关键词
COVID-19; Embolism and Thrombosis; Lower Extremity;
D O I
10.12659/AJCR.928471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patient: Female, 76-year-old Final Diagnosis: Lower limb ischemia Symptoms: Leg pain Medication: - Clinical Procedure: - Specialty: General and Internal Medicine Objective: Unusual clinical course Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which has become a global pandemic. The typical symptoms are fever, cough, and shortness of breath, but the disease can present with atypical signs, including those associated with a hypercoagulable state. These signs include deep venous thrombosis, pulmonary embolism, ischemic stroke, and acute coronary syndrome. Herein, we present the case of acute bilateral lower-extremity ischemia as a thromboembolic complication in a patient with COVID-19. Case Report: A 76-year-old woman presented with acute bilateral lower-extremity ulcerations covered with eschar formation of several weeks' duration. During her hospital course, she underwent a test for COVID-19 and the result was positive. An angiogram of the patient's lower extremities showed occlusions of the right distal posterior tibial artery, right mid-distal anterior tibial artery, right dorsalis pedis artery, left mid-distal anterior tibial artery, left dorsalis pedis artery, and left popliteal vein. Tissue plasminogen activator was administered to treat the occlusions. On the following day, the patient had an acute decline in her neurologic state and was emergently intubated. A computed tomography scan of the brain confirmed a subarachnoid hemorrhage requiring reversal of tissue plasminogen activator. The patient was transitioned to comfort care and ultimately died. Conclusions: In conclusion, acute limb ischemia should be acknowledged as a rare complication associated with COVID-19. It is important to raise awareness of arterial thrombosis as a possible complication of the hypercoagulable state caused by SARS-CoV-2 because prompt recognition is essential for early diagnosis and treatment. These actions could have a significant impact on patients' overall outcome.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 7 条
[1]   The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management [J].
Abou-Ismail, Mouhamed Yazan ;
Diamond, Akiva ;
Kapoor, Sargam ;
Arafah, Yasmin ;
Nayak, Lalitha .
THROMBOSIS RESEARCH, 2020, 194 :101-115
[2]   COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge [J].
Baj, Jacek ;
Karakula-Juchnowicz, Hanna ;
Teresinski, Grzegorz ;
Buszewicz, Grzegorz ;
Ciesielka, Marzanna ;
Sitarz, Ryszard ;
Forma, Alicja ;
Karakula, Kaja ;
Flieger, Wojciech ;
Portincasa, Piero ;
Maciejewski, Ryszard .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) :1-22
[3]   Acute limb ischemia in patients with COVID-19 pneumonia [J].
Bellosta, Raffaello ;
Luzzani, Luca ;
Natalini, Giuseppe ;
Pegorer, Matteo Alberto ;
Attisani, Luca ;
Cossu, Luisa Giuseppina ;
Ferrandina, Camillo ;
Fossati, Alessandro ;
Conti, Elena ;
Bush, Ruth L. ;
Piffaretti, Gabriele .
JOURNAL OF VASCULAR SURGERY, 2020, 72 (06) :1864-1872
[4]   Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management [J].
Cooper, Isabella D. ;
Crofts, Catherine A. P. ;
DiNicolantonio, James J. ;
Malhotra, Aseem ;
Elliott, Bradley ;
Kyriakidou, Yvoni ;
Brookler, Kenneth H. .
OPEN HEART, 2020, 7 (02)
[5]  
Cuker A, 2020, Coronavirus disease 2019 (COVID-19): hypercoagulability
[6]  
Kaur P, 2020, HEMATOL ONCOL STEM C
[7]  
World Health Organization, WHO Coronavirus Disease (COVID-19)